桂林三金(002275) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was CNY 429,589,921.89, representing a 30.71% increase compared to CNY 328,651,865.72 in the same period last year[10] - Net profit attributable to shareholders for Q1 2021 was CNY 97,672,179.84, up 27.19% from CNY 76,791,683.43 in the previous year[10] - The net profit after deducting non-recurring gains and losses was CNY 95,252,240.18, reflecting a 34.76% increase from CNY 70,683,852.98 year-on-year[10] - The basic earnings per share for Q1 2021 was CNY 0.17, a 30.77% increase from CNY 0.13 in the same period last year[10] - Total revenue for the reporting period increased by 30.71% to 429,589,921.89 from 328,651,865.72 in the same period last year[21] - The company's net profit for the first quarter of 2021 is expected to show significant changes compared to the same period last year[34] Assets and Liabilities - The total assets at the end of the reporting period were CNY 3,997,591,280.48, a 2.97% increase from CNY 3,882,273,181.59 at the end of the previous year[10] - The net assets attributable to shareholders at the end of the reporting period were CNY 3,057,509,238.36, up 3.33% from CNY 2,959,001,855.77 at the end of the previous year[10] - The total liabilities of the company are RMB 940.08 million, compared to RMB 923.27 million previously[49] - The total current assets as of March 31, 2021, amount to RMB 2.38 billion, showing a slight increase from RMB 2.38 billion on the previous date[43] - The total non-current assets were CNY 1,502,375,855.29, unchanged from the previous period[88] Cash Flow - The net cash flow from operating activities for Q1 2021 was CNY 173,928,071.94, an increase of 5.04% compared to CNY 165,577,116.28 in the same period last year[10] - Cash received from operating activities increased by 497.05% to 20,620,055.56, mainly due to government subsidies and increased employee loan recoveries[24] - Cash inflow from investment activities reached CNY 469.57 million, significantly higher than CNY 326.54 million in the prior year, marking a 43.7% increase[80] - Cash outflow from investment activities was CNY 454.17 million, down from CNY 536.23 million, indicating a 15.3% decrease[80] - The ending balance of cash and cash equivalents was CNY 1,076.97 million, up from CNY 699.34 million, showing a 54% increase[82] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,993[14] - The company has utilized a total of RMB 813.76 million from the raised funds, with a net interest income of RMB 38.06 million as of March 31, 2021[33] - As of March 31, 2021, the balance of raised funds is RMB 51.16 million, including accumulated net interest income[33] Expenses and Costs - Operating costs rose by 47.62% to 127,893,037.17, primarily due to increased sales and higher trial production costs in Shanghai[21] - Research and development expenses for Q1 2021 amounted to ¥62,817,958.41, compared to ¥52,076,652.33 in Q1 2020, indicating a growth of 20.54%[62] - The company reported a 150.79% increase in interest expenses to 11,549,263.17, primarily due to higher long-term loan interest[21] Other Financial Metrics - The weighted average return on equity for Q1 2021 was 3.25%, an increase of 0.56% from 2.69% in the previous year[10] - The company reported a decrease in other comprehensive income, with a value of -RMB 307,797.66[52] - The total profit margin for the current period was approximately 38.3%, compared to 31.3% in the previous period, indicating improved profitability[69]